NDC 51808-203

SIncalide

Sincalide

SIncalide is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Anazaohealth Corporation. The primary component is Sincalide.

Product ID51808-203_8f9023fb-e982-440a-a9ee-374c4bf3153b
NDC51808-203
Product TypeHuman Prescription Drug
Proprietary NameSIncalide
Generic NameSincalide
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2012-06-19
Marketing CategoryUNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
Labeler NameAnazaoHealth Corporation
Substance NameSINCALIDE
Active Ingredient Strength3 ug/1
Pharm ClassesCholecystokinin [CS],Cholecystokinin Analog [EPC]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 51808-203-01

1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 PACKAGE (51808-203-01)
Marketing Start Date2012-06-19
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 51808-203-01 [51808020301]

SIncalide INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryUnapproved drug other
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2012-06-19
Inactivation Date2019-11-13

Drug Details

Active Ingredients

IngredientStrength
SINCALIDE3 ug/1

OpenFDA Data

SPL SET ID:c56a824b-a8ba-42db-b05c-49c731130879
Manufacturer
UNII

Pharmacological Class

  • Cholecystokinin [CS]
  • Cholecystokinin Analog [EPC]

NDC Crossover Matching brand name "SIncalide" or generic name "Sincalide"

NDCBrand NameGeneric Name
51808-203SIncalideSincalide
70511-131SincalideSincalide
72266-248SincalideSincalide
0270-0556KINEVACsincalide

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.